Drug Trial Radar · NCT04930796
Food Effect Study of VER-01 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Nov 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Aug 10, 2022
Primary completion
Nov 17, 2022
Study completion Nov 24, 2022
Sponsor
- Lead sponsor
- Vertanical GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 18, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Evaluation of pharmacokinetics, tolerability and safety of VER-01 depending on the intake a high-fat meal in healthy volunteers
Conditions
- Healthy
Interventions
VER-01Drug
standardised cannabis extract (containing 21 mg THC per gram drug product)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetic profile of Δ9-tetrahydrocannabinol [THC] - AUC 0-tTime frame: On Day 1 and Day 4
- Pharmacokinetic profile of Δ9-tetrahydrocannabinol [THC] - AUC 0-∞Time frame: On Day 1 and Day 4
- Pharmacokinetic profile of Δ9-tetrahydrocannabinol [THC] - C maxTime frame: On Day 1 and Day 4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Medicine in Vienna - Department of Clinical Pharmacology
Vienna, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.